Skip to content
healthcare.dev

ENTECAVIR

NDC 50771-013, entecavir, tablet, film coated, from Yaopharma Co., Ltd..

Product NDC
50771-013
Status
Listed
Labeler
Yaopharma Co., Ltd.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212201
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50771-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENTECAVIR.5 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
50771-013-015077100130130 TABLET, FILM COATED in 1 BOTTLE (50771-013-01)
50771-013-025077100130290 TABLET, FILM COATED in 1 BOTTLE (50771-013-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/73dea2a4-a596-477f-b66d-5a80dd019837

Use it

Look up 50771-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50771-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50771-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.